Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Unpacking talent and reimbursement issues at Advanced Therapies Week 2022
People and patients were top of mind at Advanced Therapies Week 2022 (ATW2022) in Miami Beach, Florida, which shouldn’t come as a surprise to anyone in the industry or following the industry. Talent is a big issue right now. Good people are moving around and replacing them is difficult. It’s a challenge to fill manager-level […]
Right Turn: Commercializing Living Therapies podcast
In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing Living Therapies with CCRM will feature cell and gene therapy industry […]
Right Turn: Advanced Therapies Week 2022 from the personal to the big picture
Everything was a little different at this year’s (January 25-28) Advanced Therapies Week: from the new venue (Miami Beach Convention Centre), to the COVID-19 precautions, to one less track (stem cell talks were removed) and the replacement of the boat cruise networking event with a beach networking event, the conference was slightly altered from what […]